Abbott to Split Into Two Firms Focusing on Drug Areas
743 views · Published 19 October 2011 · 1:49 · Indexed 25 September 2026
Channel: Bloomberg Originals · 2011 · Entertainment
Oct. 19 (Bloomberg) -- Abbott Laboratories, the maker of infant formula, heart stents and prescription drugs, will split into two companies, with one selling generic drugs and medical devices and the other research-based medicines. Shannon Pettypiece reports on Bloomberg Television's "In the Loop." (Source: Bloomberg)
More from this channel
-
0:17
Pens Tie Stanley Cup Series - Bloomberg
-
0:35
Hardware Price Too High - Activision - Bloomberg
-
0:31
FDIC Seeks Citigroup Shares-Up - WSJ - Bloomberg
-
0:44
Bank Have More Accounting Leeway - Bloomberg
-
0:32
Lakers Beat Magic 100-75 - Bloomberg
-
0:30
Johnson Wins 300th Game - Bloomberg
-
1:13
GM Expects To Sell Saturn To Penske Automotive - Bloomberg
-
1:01
Broadway At Tony Awards - Bloomberg